Novo Holdings A/S Long-Term Concentrated

CIK: 0001388325 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $1,314,624 (100.0% shares, 0.0% debt)

Holdings (31)

VTI VANGUARD INDEX FDS 21.7%

Value ($000) $285,435 Shares 1,038,550 Est. Cost $267.51 Unrealized —

BN BROOKFIELD CORP 9.3%

Value ($000) $122,159 Shares 2,330,830 Est. Cost $22.16 Unrealized +69.6%

EWTX EDGEWISE THERAPEUTICS INC 9.0%

Value ($000) $117,700 Shares 5,350,000 Est. Cost $18.02 Unrealized +45.6%

ASML ASML HOLDING N V 8.4%

Value ($000) $109,888 Shares 165,836 Est. Cost $662.32 Unrealized —

CRM SALESFORCE INC 5.6%

Value ($000) $73,209 Shares 272,801 Est. Cost $193.03 Unrealized +60.1%

MIRM MIRUM PHARMACEUTICALS INC 5.1%

Value ($000) $67,575 Shares 1,500,000 Est. Cost $12.27 Unrealized +284.3%

INSM INSMED INC 4.2%

Value ($000) $55,285 Shares 724,666 Est. Cost $23.10 Unrealized +231.1%

RXRX RECURSION PHARMACEUTICALS IN 3.9%

Value ($000) $51,129 Shares 9,665,128 Est. Cost $6.72 Unrealized +8.4%

BABA ALIBABA GROUP HLDG LTD 3.7%

Value ($000) $49,233 Shares 372,327 Est. Cost $165.09 Unrealized —

CRNX CRINETICS PHARMACEUTICALS IN 3.3%

Value ($000) $42,764 Shares 1,275,000 Est. Cost $23.80 Unrealized +56.9%

BMRN BIOMARIN PHARMACEUTICAL INC 2.6%

Value ($000) $34,638 Shares 490,000 Est. Cost $84.22 Unrealized -20.1%

AVBP ARRIVENT BIOPHARMA INC 2.6%

Value ($000) $34,616 Shares 1,872,142 Est. Cost $20.52 Unrealized +19.3%

PCVX VAXCYTE INC 2.6%

Value ($000) $34,550 Shares 915,000 Est. Cost $39.88 Unrealized +100.5%

— MERUS N V 2.5%

Value ($000) $33,214 Shares 789,129 Est. Cost $56.95 Unrealized —

VRDN VIRIDIAN THERAPEUTICS INC 2.3%

Value ($000) $30,334 Shares 2,250,300 Est. Cost $16.80 Unrealized +1.4%

PHVS PHARVARIS N V 2.1%

Value ($000) $27,083 Shares 1,725,000 Est. Cost $15.26 Unrealized +10.5%

FOLD AMICUS THERAPEUTICS INC 1.7%

Value ($000) $22,440 Shares 2,750,000 Est. Cost $12.51 Unrealized -26.0%

CLDX CELLDEX THERAPEUTICS INC NEW 1.7%

Value ($000) $21,780 Shares 1,200,000 Est. Cost $34.88 Unrealized -35.9%

— BLUEPRINT MEDICINES CORP 1.5%

Value ($000) $20,251 Shares 228,804 Est. Cost $66.51 Unrealized —

ZBIO ZENAS BIOPHARMA INC 1.3%

Value ($000) $17,498 Shares 2,214,967 Est. Cost $14.68 Unrealized -46.7%

CBLL CERIBELL INC 1.3%

Value ($000) $16,905 Shares 880,000 Est. Cost $24.11 Unrealized -7.8%

— VERVE THERAPEUTICS INC 1.0%

Value ($000) $13,710 Shares 3,000,000 Est. Cost $10.86 Unrealized —

RCKT ROCKET PHARMACEUTICALS INC 0.6%

Value ($000) $7,337 Shares 1,100,000 Est. Cost $28.09 Unrealized -64.8%

FDMT 4D MOLECULAR THERAPEUTICS IN 0.5%

Value ($000) $6,299 Shares 1,950,000 Est. Cost $14.59 Unrealized -67.7%

LXEO LEXEO THERAPEUTICS INC 0.3%

Value ($000) $3,895 Shares 1,122,581 Est. Cost $13.07 Unrealized -66.1%

— LANZATECH GLOBAL INC 0.3%

Value ($000) $3,829 Shares 15,814,845 Est. Cost $3.88 Unrealized —

IOBT IO BIOTECH INC 0.3%

Value ($000) $3,656 Shares 3,354,449 Est. Cost $6.26 Unrealized -84.9%

KYTX KYVERNA THERAPEUTICS INC 0.3%

Value ($000) $3,571 Shares 1,850,000 Est. Cost $19.62 Unrealized -84.9%

ABCL ABCELLERA BIOLOGICS INC 0.2%

Value ($000) $2,513 Shares 1,126,915 Est. Cost $8.47 Unrealized -66.1%

MQ MARQETA INC 0.1%

Value ($000) $1,819 Shares 441,558 Est. Cost $22.37 Unrealized -82.4%

GLTO GALECTO INC 0.0%

Value ($000) $310 Shares 99,913 Est. Cost $13.05 Unrealized -63.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
VTI	VANGUARD INDEX FDS	1,038,550	$285,435	21.7%	$267.51	—	TOTAL STK MKT	922908769
BN	BROOKFIELD CORP	2,330,830	$122,159	9.3%	$22.16	+69.6%	CL A LTD VT SH	11271J107
EWTX	EDGEWISE THERAPEUTICS INC	5,350,000	$117,700	9.0%	$18.02	+45.6%	COM	28036F105
ASML	ASML HOLDING N V	165,836	$109,888	8.4%	$662.32	—	N Y REGISTRY SHS	N07059210
CRM	SALESFORCE INC	272,801	$73,209	5.6%	$193.03	+60.1%	COM	79466L302
MIRM	MIRUM PHARMACEUTICALS INC	1,500,000	$67,575	5.1%	$12.27	+284.3%	COM	604749101
INSM	INSMED INC	724,666	$55,285	4.2%	$23.10	+231.1%	COM PAR $.01	457669307
RXRX	RECURSION PHARMACEUTICALS IN	9,665,128	$51,129	3.9%	$6.72	+8.4%	CL A	75629V104
BABA	ALIBABA GROUP HLDG LTD	372,327	$49,233	3.7%	$165.09	—	SPONSORED ADS	01609W102
CRNX	CRINETICS PHARMACEUTICALS IN	1,275,000	$42,764	3.3%	$23.80	+56.9%	COM	22663K107
BMRN	BIOMARIN PHARMACEUTICAL INC	490,000	$34,638	2.6%	$84.22	-20.1%	COM	09061G101
AVBP	ARRIVENT BIOPHARMA INC	1,872,142	$34,616	2.6%	$20.52	+19.3%	COM	04272N102
PCVX	VAXCYTE INC	915,000	$34,550	2.6%	$39.88	+100.5%	COM	92243G108
—	MERUS N V	789,129	$33,214	2.5%	$56.95	—	COM	N5749R100
VRDN	VIRIDIAN THERAPEUTICS INC	2,250,300	$30,334	2.3%	$16.80	+1.4%	COM	92790C104
PHVS	PHARVARIS N V	1,725,000	$27,083	2.1%	$15.26	+10.5%	COM	N69605108
FOLD	AMICUS THERAPEUTICS INC	2,750,000	$22,440	1.7%	$12.51	-26.0%	COM	03152W109
CLDX	CELLDEX THERAPEUTICS INC NEW	1,200,000	$21,780	1.7%	$34.88	-35.9%	COM NEW	15117B202
—	BLUEPRINT MEDICINES CORP	228,804	$20,251	1.5%	$66.51	—	COM	09627Y109
ZBIO	ZENAS BIOPHARMA INC	2,214,967	$17,498	1.3%	$14.68	-46.7%	COM	98937L105
CBLL	CERIBELL INC	880,000	$16,905	1.3%	$24.11	-7.8%	COM	15678C102
—	VERVE THERAPEUTICS INC	3,000,000	$13,710	1.0%	$10.86	—	COM	92539P101
RCKT	ROCKET PHARMACEUTICALS INC	1,100,000	$7,337	0.6%	$28.09	-64.8%	COM	77313F106
FDMT	4D MOLECULAR THERAPEUTICS IN	1,950,000	$6,299	0.5%	$14.59	-67.7%	COM	35104E100
LXEO	LEXEO THERAPEUTICS INC	1,122,581	$3,895	0.3%	$13.07	-66.1%	COM	52886X107
—	LANZATECH GLOBAL INC	15,814,845	$3,829	0.3%	$3.88	—	COM	51655R101
IOBT	IO BIOTECH INC	3,354,449	$3,656	0.3%	$6.26	-84.9%	COM	449778109
KYTX	KYVERNA THERAPEUTICS INC	1,850,000	$3,571	0.3%	$19.62	-84.9%	COM	501976104
ABCL	ABCELLERA BIOLOGICS INC	1,126,915	$2,513	0.2%	$8.47	-66.1%	COM	00288U106
MQ	MARQETA INC	441,558	$1,819	0.1%	$22.37	-82.4%	CLASS A COM	57142B104
GLTO	GALECTO INC	99,913	$310	0.0%	$13.05	-63.9%	COM NEW	36322Q206